Enveric Biosciences, Inc. — Director's Dealing 2017

May 8, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMERI Holdings, Inc. (AMRH)
CIK: 0000890821
Period of Report: 2017-05-04

Reporting Person: Patel Viraj J (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-05-04	Option (Right to Buy)	$6.59	A	75000	Acquired	2022-05-04	Common Stock (75000)	Direct

Footnotes

F1: The Option vests as follows: (a) as to 25,000 shares of common stock of the Issuer ("Stock), on May 4, 2018, (b) as to a further 25,000 shares of Stock, on May 4, 2019, and (c) as to the remaining 25,000 shares of Stock, on May 4, 2020.